anastrozole has been researched along with dinoprostone in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (80.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Bulun, SE; Sasano, H; Takayama, K; Zeitoun, KM | 1 |
Bulun, SE; Takayama, K | 1 |
Goss, PE; Strasser-Weippl, K | 1 |
Burnett-Bowie, SA; Dere, ME; Leder, BZ; Lee, H; Roupenian, KC | 1 |
2 review(s) available for anastrozole and dinoprostone
Article | Year |
---|---|
Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance.
Topics: Anastrozole; Aromatase; Aromatase Inhibitors; Dinoprostone; Endometriosis; Enzyme Inhibitors; Estrogens; Estrone; Female; Humans; Middle Aged; Mullerian Ducts; Nitriles; Pregnancy; Triazoles | 2000 |
[Endometriosis and aromatase inhibitor].
Topics: Anastrozole; Aromatase; Aromatase Inhibitors; Dinoprostone; Endometriosis; Enzyme Inhibitors; Estrogen Antagonists; Estrogens; Fadrozole; Female; Humans; Middle Aged; Nitriles; Triazoles | 2001 |
1 trial(s) available for anastrozole and dinoprostone
Article | Year |
---|---|
Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Anastrozole; Aromatase Inhibitors; Biological Availability; Body Composition; Dinoprostone; Double-Blind Method; Humans; Hypogonadism; Male; Middle Aged; Nitriles; Outcome Assessment, Health Care; Testosterone; Triazoles | 2009 |
2 other study(ies) available for anastrozole and dinoprostone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Prevention strategies with aromatase inhibitors.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Cyclooxygenase 2; Dinoprostone; Enzyme Inhibitors; Female; Humans; Isoenzymes; Membrane Proteins; Models, Biological; Neoplasms; Nitriles; Placebos; Postmenopause; Prostaglandin-Endoperoxide Synthases; Receptors, Estrogen; Tamoxifen; Time Factors; Triazoles | 2004 |